Release Date: 12/01/09 10:39 Summary: Alinta EATM Asset Sale Price Sensitive: Yes Download Document 91.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%